Discontinuation of the liposomal delivery of bupivacaine has no effect on pain management after primary total knee arthroplasty: no effect on pain scores, opioid consumption, or functional status

摘要

Liposomal bupivacaine (LB) as part of a periarticular injection protocol continues to be a highly debated topic in total knee arthroplasty (TKA). We evaluated the effect of discontinuing the use of LB in a periarticular protocol on immediate postoperative pain scores, opioid consumption, and objective functional outcomes.